Digital health technologies (DHTs) enable remote data collection, support a patient-centric approach to drug development, and provide real-time data in real-world settings. With increasing use of DHTs in clinical care and development, we expect…
Continue Reading
Multinational digital health firm Babylon reported its previously announced business combination with digital neurotherapy company MindMaze is not moving forward, and it will pursue the sale of its U.K. business to third parties and…
Continue Reading
The Startup, which was Valued at $1.4 Billion in 2021, has Developed a Platform that uses AI to Combine Professional Medical Knowledge with Patient Clinical Data, Providing Doctors and Users with Information about the…
Continue Reading
